-

Thomas H. Lee Partners Hires Shahab Vagefi as Managing Director

Vagefi to Focus on Healthcare IT Opportunities

BOSTON--(BUSINESS WIRE)--Thomas H. Lee Partners, L.P. (“THL”), a premier private equity firm investing in middle market growth companies, today announced that Shahab Vagefi has joined the firm as a Managing Director in THL’s Healthcare vertical.

“We are very pleased to welcome Shahab to THL as we continue expanding our healthcare team,” said Joshua Nelson, Managing Director and Head of the Healthcare vertical at THL. “Shahab is a seasoned healthcare investor and brings significant experience sourcing and growing businesses in Healthcare IT. Our team is passionate about the continued opportunity to invest in companies that improve the healthcare ecosystem, and Shahab brings that same level of enthusiasm.”

Mr. Vagefi joins THL with over a decade of healthcare private equity experience. Most recently, he was a Founding Partner at Martis Capital, a middle-market private equity firm focused on Healthcare Services, Information Technology, Products & Diagnostics, and Consumer & Wellness verticals. In this role, Mr. Vagefi helped lead daily operations of the firm and was involved in all aspects of sourcing, evaluating, executing, and managing investment opportunities.

“I am excited to join THL and work with the team to identify differentiated healthcare investment opportunities,” said Mr. Vagefi. “THL has an outstanding reputation in the healthcare space and I am impressed by the depth and breadth of their capabilities. I look forward to building on the current strategy to drive growth and value.”

Prior to Martis Capital, Mr. Vagefi was a Senior Associate at The Carlyle Group from 2007 to 2010. Mr. Vagefi began his career as an investment banker holding positions at JP Morgan and Credit Suisse. Mr. Vagefi holds a B.A. and M.A. from Johns Hopkins University and an M.B.A from the Kellogg School of Management at Northwestern University.

Over the past 20 years, THL has invested approximately $5 billion in over 20 healthcare companies, including Nextech, SeniorLink, Curo Hospice, Syneos Health, and Intermedix. THL invests within five identified sector opportunities (“ISOs”) within healthcare: Consumer Healthcare, Home-Based Care, Healthcare IT, Medtech Services, and Pharma Services.

About Thomas H. Lee Partners

Thomas H. Lee Partners, L.P. (“THL”) is a premier private equity firm investing in middle market growth companies exclusively in three sectors: Financial Services, Healthcare and Technology & Business Solutions. THL couples deep sector expertise with dedicated internal operating resources to transform and build great companies of lasting value in partnership with management. The Firm’s domain expertise and resources help to build great companies with an aim to accelerate growth, improve operations and drive long-term sustainable value. Since 1974, THL has raised more than $30 billion of equity capital, invested in over 160 companies and completed more than 500 add-on acquisitions representing an aggregate enterprise value at acquisition of over $210 billion. THL invests in automation companies through its flagship private equity fund and a dedicated automation fund. For more information, please visit www.thl.com.

Contacts

Tim Quinn
Edelman
Timothy.Quinn@edelman.com
646.258.2308

Thomas H. Lee Partners, L.P.


Release Versions

Contacts

Tim Quinn
Edelman
Timothy.Quinn@edelman.com
646.258.2308

More News From Thomas H. Lee Partners, L.P.

THL Partners Raises $6.35 Billion of Investable Capital for Fund X

BOSTON--(BUSINESS WIRE)--THL Partners, a premier private equity firm investing in middle-market growth companies, today announced the final close of THL Equity Fund X, L.P. (“Fund X”) with $6.35 billion in investable capital. Fund X received strong support from a diverse group of both existing and new investors, including public and corporate pension funds, sovereign wealth funds, financial institutions, and family offices across North America, Latin America, Europe, Asia, Australia, and the Mi...

Celerion Announces Majority Investment from THL Partners

LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, a global leader in clinical pharmacology and bioanalytical sciences, today announced a majority investment from THL Partners (“THL”), a premier private equity firm investing in middle market growth companies. The investment will support Celerion’s continued growth and innovation, including expanding its clinical and bioanalytical capabilities and advancing its work to help pharmaceutical and biotechnology partners bring new therapies to patients worldwi...

Thomas H. Lee Partners Appoints Healthcare and Employee Benefits Industry Leader Dave Guilmette as Executive Partner

BOSTON--(BUSINESS WIRE)--THL Partners (“THL”), a premier private equity firm investing in middle-market growth companies, today announced that Dave Guilmette has joined the firm as an Executive Partner in its Financial Technology & Services investment group. Guilmette brings over 40 years of experience in building, leading, and transforming global healthcare and employee benefits businesses. In his role, Guilmette will support THL’s efforts to identify, source, and grow investment opportuni...
Back to Newsroom